Polyunsaturated fats have been linked to occurrences of sporadic colon cancer. One possible cause may be degradation of polyunsaturated fats during cooking, resulting in multiple reactive carbonyl species (RCS) that can damage nuclear DNA and proteins, particularly in rapidly dividing colon crypt cells.
Introduction
Reactive carbonyl species (RCS) are predominant products of lipid peroxidation, generated primarily as a result of oxidative degradation of lipid hydroperoxides [1, 2] .
It is also known for RCS to be generated via oxidative sugar degradation [3] as well as being released into the environment from car exhaust fumes and cigarette smoke [4, 5] . The oxidation of dietary polyunsaturated fatty acids (PUFAs) during food processing and cooking is gaining increasing importance as a source of RCS that may have deleterious effects within the digestive tract [6, 7, 8] . This is especially problematic in Western countries, where diets high in polyunsaturated fatty acids have been associated with an increased risk of sporadic colorectal cancer [9] [10] [11] [12] .
A well-established hypothesis for the initiation of colonic neoplasia may be as a result of the oxidation of dietary PUFAs during the cooking process [13] and food storage. Redox cycling food chemicals formed during food processing or present as contaminants [6] can, through an autocatalytic process, initiate peroxidation of PUFA and additionally, lipoproteins present as cellular components of the gastrointestinal mucosa. Extensive studies by Wilson et al. , [14] and Linsteisen and Wolfram [8] have shown that foodstuffs contain oxidised lipids that are readily absorbed from the diet.
PUFAs are readily oxidisable compounds leading to the production of lipid hydroperoxides that decompose to form an extensive number of reactive carbonyl compounds such as malondialdehyde (MDA) and 4-hydroxynonenals (4-HNE) which, in particular, show significant cytotoxicity and mutagenicity following adduction with DNA and protein [15] .
Human exposure to RCS is potentially widespread via both endogenous and exogenous sources. Evidence for the generation of RCS has been extensively reviewed, especially in terms of thiobarbituric acid reactive products (TBARS) and 4-3 RCS-modified DNA in colonocytes hydroxy-trans-2-nonenal (HNE)-modified proteins, in diabetes and atherosclerosis [16, 17] , Alzheimer's disease [18] and colon cancer [19, 20, 21] . The colonic mucosa is composed of crypts lined with epithelial cells, all of which are at varying degrees of proliferation and differentiation. Precursor, or stem cells, lining the base of the crypt are undifferentiated and have a large proliferative capacity, and these cells migrate towards the luminal surface [22, 23, 24] . We propose here, that these undifferentiated, proliferating cells represent a target population for carcinogenesis and that damage to these cells from RCS carries an increased likelihood of initiating carcinogenesis.
DNA adducts formed by RCS are known to possess strong miscoding potential in vitro [25] and of the DNA adducts formed by MDA, pyrimido(1,2α)purin-10(3H)one (M 1 G) is readily detected in many human tissues.
Other propano-adducts also originate from α,β-unsaturated aldehydes or enals such as acrolein (Acr), crotonaldehyde (Cro), glyoxal (Gly) and HNE. Adducts formed by HNE have been detected in healthy human colon tissue [26] . Etheno-DNA adducts are formed from the epoxides of enals and elevated levels of this type reflect the extent of oxidative stress [27] . Antibodies, both poly-and mono-clonal, have been generated against RCS-modified DNA bases. For example, MDA-deoxyguanosine [28] , deoxycytidine-glyoxal [29] , deoxyadenosine-acrolein [30] , 1,N(6)-ethenodeoxyadenosine [31] and ethenodeoxyguanosine [32] . These specific RCS-DNA antibodies have been successfully used to measure carbonyl stress in human and animal studies following oxidative and peroxidative insult [33, 34] . However, in an attempt to monitor global carbonyl stress (DNA and protein) we describe the 
Materials and Methods

General materials
Calf thymus DNA was from Calbiochem Novabiochem UK Ltd (Nottingham UK). Modification of DNA was assessed by direct binding ELISA utilising an anti-reactive oxygen species antibody, as described in [35] . Increased binding of antibody over that to native DNA was seen for each aldehyde modified DNA (results not shown).
96-well
Preparation of reactive carbonyl species-modified BSA or LDL
BSA (1 mg/ ml) and LDL (1 mg/ ml) were modified as described for calf thymus DNA.
Production of anti-(RCS-DNA) polyclonal antiserum
Immunisation of a New Zealand White rabbit was as described previously for Reactive Oxygen Species -modified DNA (ROS-modified DNA, [32] ). The immunogen was prepared using equal volumes of individually modified RCS-DNA.
Immunoglobulin G purification using protein-A.
Prior to characterisation, the anti-(RCS-DNA) antiserum was purified to obtain the IgG fraction using a protein A column. Briefly, 0.125 g Protein A beads (cyanogen 6 RCS-modified DNA in colonocytes bromide activated and immobilised on sepharose CL-4B) were allowed to swell in water (1 g swells to ≈ 4 ml) and passed through a 1 ml column with a bed of glass wool. Antiserum (1 ml) was adjusted to pH 8.0 with 1 M Tris-base and layered onto the protein A column which had been pre-washed using 5 column volumes of 100 mM Tris, pH 8.0. Following washing with a further 10 column volumes of 100 mM Tris, pH 8.0, IgG was eluted with 10-column volumes of 100 mM glycine, pH 3.0.
Each column volume was collected in 1.5 ml aliquots containing 50 μL 1 M Tris, pH 8.0. IgG containing fractions were identified by UV absorbance at 280 nm (1 OD ≈ 0.8 mg/ ml), and subsequently combined. The final concentration of IgG was 1.78 mg/ ml.
Enzyme-linked immunosorbent assay (ELISA)
Characterisation of the anti-(RCS-DNA) antiserum was carried out using direct and inhibition ELISA, as previously described [35] . IgG fraction of the antiserum was used at a final dilution of 1:500 (3.6µg/ml) and secondary peroxidase-labelled antirabbit conjugate at a dilution of 1:2000.
Preparation of heat-oxidised oil mixture
In order to simulate the effects of exposure to exogenous (dietary) products of lipid peroxidation, a heat-oxidised oil mixture was prepared as follows: 1 ml of Methyl- Prior to incubation with cells, a PBS extract of the oil mixture was prepared as follows: 300 ml of heat-oxidised oil was added to 2.7 ml PBS and vortex mixed for 2 7 RCS-modified DNA in colonocytes min, followed by rotational mixing for a further 10 min. The oil/PBS mixture was then centrifuged at 1300 g for 5 min and the upper aqueous phase was removed for immediate use.
Human colon epithelial cell culture
The human normal colon cell line CRL-1807 transformed with heat sensitive SV40 
Exposure of CRL-1807 cells to products of lipid peroxidation
Two models were used to simulate exposure of colon cells to products of lipid Untreated CRL-1807 cells, or cells treated with oil which had not been heat oxidised, were used as controls. Following treatment, the medium was removed and cells were washed twice with cold PBS. Cells were then fixed with 100 % ice-cold ethanol for 5 min, following which excess ethanol was discarded and cells allowed to dry at RT.
Immunocytochemical analysis
CRL-1807 cells previously exposed to products of lipid peroxidation using either 
Imaging software
Images were viewed on an Axioskop fluorescence microscope (magnification x 40) and captured using a Hamamatsu 12-bit digital camera. FITC or DAPI filters were 9 RCS-modified DNA in colonocytes placed on a 10-position filter wheel, and controlled using Openlab 3.14 software (Improvision, University of Warwick Science Park, Coventry, UK). Images were originally captured as a 12-bit greyscale image, following which DAPI images were coloured as red (nuclear counterstain) and anti-(RCS-DNA) antiserum binding as green. DAPI and FITC images were subsequently superimposed to assess specific antibody binding to nuclear DNA (yellow/orange).
Immunohistochemical analysis of ex vivo colon tissue
Samples of 'normal' colon tissue were obtained from ten patients undergoing surgery for colon cancer, nine of whom were subsequently diagnosed with colon cancer.
Tissue samples were initially frozen in liquid nitrogen and stored at -80°C. Sections were thawed prior to tissue sectioning (8 µm thickness) and plated onto microscope All sections were subsequently stored in a light-tight container at 4°C prior to analysis, as described previously.
Results
Antigenicity of RCS-modified DNA
At regular intervals throughout the immunisation schedule, test bleeds were screened by direct ELISA for reactivity against native DNA, the immunogen (comprising a [Insert Figure 1 about here]
The antiserum was further characterised against double-and single-stranded (ds-and ss-DNA) antigens by inhibition ELISA, utilising GLY-DNA as solid phase antigen and anti-(RCS-DNA) antiserum at a dilution of 1:500 (Table 1 ). Increased reactivity of the anti-(RCS-DNA) antiserum over that to native DNA was observed towards HNE-, GLY-and ACR-modified DNA for both ds-and ss-antigens. For GLY-DNA, the antiserum was considerably more reactive with the ds antigen, in comparison with the ss antigen (IC 50 values of 7 and 178 µg/ ml respectively). In contrast, reactivity of the anti-(RCS-DNA) antiserum to ssCROT-DNA and ssHNE-DNA (IC 50 values > 300 and 175 µg/ ml respectively) was generally greater than that to the ds antigens (IC 50 values of > 400 and 265 µg/ ml for dsCROT-DNA and dsHNE-DNA respectively).
[Insert Table 1 about here]
Cross-reactivity of anti-(RCS-DNA) antiserum to RCS-modified proteins
The immunogen used to generate the anti-(RCS-DNA) antiserum was hydrostatically bound to a protein hapten (BSA) and therefore the antiserum has a potential for crossreactivity to RCS-modified proteins. This was assessed by direct ELISA utilising RCS-modified BSA as antigen. In addition, reactivity to RCS modified low density lipoprotein (LDL) was also investigated as the apolipoprotein component of LDL contains a large proportion of lysine residues which is known to be highly reactive with carbonyl species. Minimal reactivity of the antiserum above that seen to the native antigen was noted for all RCS-modified antigens. However, binding of the anti-(RCS-DNA) antiserum to MDA-modified LDL was seen to be significantly raised RCS-modified DNA in colonocytes above that of native LDL (mean abs ± s.d. of 1.1025 ± 0.014 and 0.458 ± 0.032 respectively; P < 0.0001; described but not shown). [Insert Figure 3 about here]
Utilisation of anti-(RCS-DNA) antiserum for detection of RCS-modified
Discussion
In this manuscript we describe the characterisation and application of a novel polyclonal antiserum raised against an immuogen comprising a mixture of DNA modified with RCS. The RCS selected for inclusion in this study focused on those known to have significant cytotoxic and mutagenic properties when adducted with DNA or protein [15] and to be present in human tissues [25] [26] [27] . The application of specific RCS-DNA antibodies to measure carbonyl stress in human and animal studies has been previously described [33, 34] . In contrast, the approach adopted in this study potentially allows for monitoring of carbonyl stress (DNA and protein) at a 14 RCS-modified DNA in colonocytes more global (but not totally inclusive) level, and was successfully demonstrated in human colonic cells exposed to RCS derived from lipid peroxidation.
Using direct binding ELISA against DNA modified with individual RCS as antigen, an apparent order of reactivity of the anti-(RCS-DNA) antiserum was demonstrated as HNE > GLY > ACR > CROT > MDA. The effect of using the RCSmodified antigens in the ds-or ss-form on antiserum reactivity was assessed by inhibition ELISA. In general, reactivity was seen to be similar to both ds-and ss-RCS-modified antigens with the exception of glyoxal-DNA where the antiserum demonstrated considerably greater reactivity to the ds-antigen than to the ss-antigen.
MDA-DNA was seen to be less antigenic for the anti-(RCS-DNA) antiserum than native DNA; however the bulky nature of MDA-DNA may have made this antigen unsuitable for use in this type of ELISA format.
It was not within either the aims or the scope of this study to fully characterise the adducts produced during reaction of each RCS with DNA. However, it is possible using published literature for us to postulate the identity of the main adducts formed.
The reaction of DNA with HNE was carried out in this study in a comparable way to that described by Douki et al. [38] who identified 1, N 2 -propano-2′-deoxyguanosine as the major adduct formed from the reaction, with 1, N 6 -ethenoadenine and 1-N 2 -ethenoguanine also being produced, but at significantly lower levels. Similarly, Olsen et al. [39] reported that, under comparable reaction conditions to ours, the major adduct formed from the reaction of Glyoxal and DNA was 2′-deoxyguanosine-glyoxal with 2′-deoxyadenosine-glyoxal adduct also being formed at lower levels. From the study described by Pawlowicz et al, [39] we can also postulate that 2′-deoxyadenosine-acrolein adducts are the likely main adducts formed from the reaction of acrolein with DNA, whereas reaction with Crotonaldehyde could have lead to the 15 RCS-modified DNA in colonocytes formation of Michael addition products and the Schiff base N 2 -(3-hydroxybut-1-ylidene)dG [40] . For the remaining RCS used in our study, MDA, we can surmise from the work reported by Marnett [25] that the most abundant adduct formed by reaction of MDA and DNA is likely to have been pyrimidol [1,2α] 
